共 92 条
- [1] Kennedy DL(2004)Pregnancy exposure registries Drug Saf 27 215-228
- [2] Uhl K(2005)Methodological issues in the epidemiological study of the teratogenicity of drugs Congenit Anom (Kyoto) 45 44-51
- [3] Kweder SL(2003)Case-crossover and case-time-control designs in birth defects epidemiology Am J Epidemiol 158 385-391
- [4] Källén BA(2011)Evolving knowledge of the teratogenicity of medications in human pregnancy Am J Med Genet C Semin Med Genet 157 175-182
- [5] Hernandez-Diaz S(2007)Promise and pitfalls of administrative data in evaluating pregnancy outcomes Pharmacoepidemiol Drug Saf 16 1181-1183
- [6] Hernan MA(2011)Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as tools for postmarketing teratogen surveillance: anticonvulsants and the risk of major congenital malformations Drug Saf 34 157-171
- [7] Meyer K(2009)Pharmacovigilance in pregnancy using population-based linked datasets Pharmacoepidemiol Drug Saf 18 211-225
- [8] Werler MM(2010)Drugs dispensed in primary care during pregnancy: a record-linkage analysis in Tayside, Scotland Drug Saf 33 593-604
- [9] Mitchell AA(2008)Pregnancy exposure registries for assessing antimalarial drug safety in pregnancy in malaria-endemic countries PLoS Med 5 e187-14
- [10] Adam MP(2012)Records linkage of electronic databases for the assessment of adverse effects of antiretroviral therapy in sub-Saharan Africa Pharmacoepidemiol Drug Saf 21 407-1210